We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NBIO market cap is 11.73M. The company's latest EPS is USD -0.0121 and P/E is -5.79.
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 750k | 1M | 0 | 0 |
Operating Income | -3.45M | -1.4M | -457k | -2.14M | -2.23M |
Net Income | -4M | -959k | -470k | -2.8M | -2.09M |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3k | 751k | 105k | 255k | 552k |
Total Liabilities | 2.88M | 1.22M | 776k | 1.55M | 809k |
Total Equity | -2.88M | -473k | -671k | -1.3M | -257k |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -554k | -987k | 414k | -1.79M | -1.19M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 426k | 985k | -321k | 1.87M | 1.39M |
Market Cap | 11.73M |
Price to Earnings Ratio | -5.79 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 31.82 |
Price to Book Ratio | -46.9 |
Dividend Yield | - |
Shares Outstanding | 172.2M |
Average Volume (1 week) | 80.82k |
Average Volume (1 Month) | 97.13k |
52 Week Change | -52.71% |
52 Week High | 0.28 |
52 Week Low | 0.0303 |
Spread (Intraday) | 0.03 (32.96%) |
Company Name | Nascent Biotech Inc (QB) |
Address |
623 17th street vero beach, florida 32960 |
Website | https://www.nascentbiotech.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions